ACIP delays vote on newborn hepatitis B vaccine
Digest more
The CDC’s Advisory Committee on Immunization Practices (ACIP) began its December 4 and 5, 2025, meeting today, launching two full days of presentations, public comment and planned votes that could reshape how infants and children receive hepatitis B (HepB) vaccines and other routine immunizations.
A panel that issues advice on U.S. vaccine policy appears prepared to vote Thursday to recommend a delay in when most babies begin to be vaccinated against hepatitis B.
MedPage Today on MSN
One dose of HPV vaccine just as effective as two, trial finds
Kreimer and colleagues also found that one dose of the nonavalent vaccine was noninferior to two doses in preventing against any of the seven carcinogenic HPV types -- HPV16, 18, 31, 33, 45, 52, or 58 -- with an observed rate difference of 0.56 infections per 100 participants (95% CI 0.01-1.11, P <0.001).
Advisers to the Centers for Disease Control Prevention will scrutinize the childhood vaccine schedule and may start to upend it.
Local pharmacists are reminding older adults and those who are immunocompromised to get a second COVID vaccine.
News-Medical.Net on MSN
Single-dose dengue vaccine will benefit populations in hard-to-reach regions
A world-first single-dose vaccine against the dengue virus, manufactured and approved for use in Brazil, will especially benefit populations in hard-to-reach regions of the country such as the Amazon,